Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Technology

Predicting variant pathogenicity with AlphaMissense

Nature Reviews Genetics volume 24, page 804 (2023)Cite this article

Subjects

A team of researchers from Google DeepMind report in Science the development of AlphaMissense, an artificial intelligence-based approach to predict the pathogenicity of missense variants adapted from their previously described protein structure prediction tool AlphaFold. Given that only ~2% of the 4 million missense variants observed in the human genome have been clinically classified, AlphaMissense has enormous potential for informing diagnosis and, possibly, therapy of rare genetic disease.

AlphaMissense is trained in two stages. The first stage, which is similar to that of AlphaFold, trains the network to predict the 3D structure of a reference sequence. In the second stage, the model is trained on human proteins to predict the pathogenicity of variants of the reference sequence. Sequences in the training set are labelled as benign if they occur frequently in human populations or pathogenic if they are absent. However, the training set is inherently noisy, because variants that are not observed in human populations could nevertheless be benign, so the preliminary model generated in stage 2 is then used to filter out unobserved variants that are likely to be benign, and the model is refined by training on the filtered dataset. Pathogenicity predictions from AlphaMissense were calibrated against an evaluation set of ClinVar variants to generate a pathogenicity score that is defined as ‘likely pathogenic’, ‘ambiguous’ or ‘likely benign’ on the basis of threshold values assigned with 90% precision on ClinVar variants. Thus, AlphaMissense combines the structural context of variants with their evolutionary conservation to predict functional effects, without direct training on previously assigned databases such as ClinVar that have curation biases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

Original article

  • Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Genetics http://www.nature.com/nrg/

    Kirsty Minton

Authors
  1. Kirsty Minton
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Kirsty Minton.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minton, K. Predicting variant pathogenicity with AlphaMissense. Nat Rev Genet 24, 804 (2023). https://doi.org/10.1038/s41576-023-00668-9

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41576-023-00668-9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing